GleamWall
中文EN

NBIX NEUROCRINE BIOSCIENCES INC

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 914475 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY38.0%
TTM net income YoY64.1%
TTM EPS YoY60.9%
Revenue 3-yr CAGR27.5%
Net income 3-yr CAGR54.4%

Margins

Gross margin97.8%
Operating margin24.0%
Net margin19.0%
FCF margin28.1%
EBITDA margin24.8%

Returns

ROE20.4%
ROA14.2%
ROIC (approx.)22.7%
Asset turnover0.75x

Leverage & solvency

Liabilities / assets31.1%
Debt / equity0.00x
Current ratio2.04x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.52x
Accruals ratio-7.3%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$2.86B$2.36B
Cost of revenue$52.10M$34.00M
Gross profit$2.81B$2.32B
R&D expense$1.02B$731.10M
SG&A expense$1.16B$1.01B
Operating income$619.10M$570.50M
Pretax income$705.40M$486.00M
Income tax$226.80M$144.70M
Net income$478.60M$341.30M
EBITDA$645.10M$594.00M
EPS (basic)4.813.40
EPS (diluted)4.673.29
Weighted avg. shares (diluted)102.50M103.70M
Balance sheet
Cash & equivalents$713.00M$241.00M
Short-term investments$767.40M$843.10M
Receivables$686.80M$479.10M
Inventory$69.00M$57.40M
Current assets$2.52B$1.72B
PP&E, net$89.80M$82.60M
Goodwill$6.10M$5.70M
Intangibles$4.70M$36.50M
Total assets$4.63B$3.72B
Current liabilities$743.40M$507.70M
Total liabilities$1.38B$1.13B
Shareholders' equity$3.25B$2.59B
Shares outstanding100.10M99.40M
Cash flow statement
Operating cash flow$782.70M$595.40M
Capital expenditure$34.00M$38.20M
Free cash flow$748.70M$557.20M
Investing cash flow-$264.40M-$126.80M
Financing cash flow-$38.30M-$486.70M
Depreciation & amortization$26.00M$23.50M
Stock-based compensation$217.90M$195.50M
Share buybacks$167.70M$300.00M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.